A new model for drug development using a multi-stakeholder consortiumBMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g1850 (Published 06 March 2014) Cite this as: BMJ 2014;348:g1850
- Anthony K Hall, consultant and charity co-founder1
- 1Findacure Development, Cambridge CB1 2BL, UK
Cohen and Raftery highlight the difficulties of new collaborative drug development models.1 Several charities now fund and collaborate in drug research and development. This can create ethical tension if donations from the public are used for commercial gain.
In 2012, I helped create a charity called Findacure (www.findacure.org.uk), which aims to teach patient groups how to drive the drug …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial